GlassScriptPhysician profile
Robin L Plank
NPI 1174503437
$1,593.23
in general payments reported to CMS, 2019-2025
14 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.39 · 2020: $29.28 · 2021: $34.45 · 2022: $16.80 · 2023: $340 · 2024: $727 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.32 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $408.62 | 2022-2025 | |
| Novo Nordisk INC | $306.85 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $261.75 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $165.61 | 2023-2024 | Veozah |
| Pfizer INC. | $159.77 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $57.38 | 2025 | Zoryve |
| Lilly USA, LLC | $51.07 | 2024-2025 | Mounjaro, Zepbound |
| Inspire Medical Systems, INC. | $44.67 | 2024-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.45 | 2021 | |
| Exact Sciences Corporation | $33.51 | 2024 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $26.02 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.90 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.45 | 2023 | Xifaxan, Trulance |
| E.R. Squibb & Sons, L.L.C. | $13.18 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Plank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.